A chemical called kynurenic acid may play a role in diseases characterised by cognitive impairments or psychosis, including schizophrenia, Alzheimer’s disease and bipolar disorder. Newly developed drugs that reduce this acid in the brain show promise in reducing symptoms of these conditions.
Comments are closed.